By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IMPAX Laboratories 

30831 Huntwood Avenue

Hayward  California  94544  U.S.A.
Phone: 510-476-2000 Fax: 510-471-3200



Drug Delivery

Company News
IMPAX Labs (IPXL) Receives Tentative FDA Approval For Generic Version Of Vytorin (ezetimibe And simvastatin) Tablets, 10 Mg/10 Mg, 10 Mg/20 Mg, 10 Mg/40 Mg And 10 Mg/80 Mg 2/2/2016 6:24:16 AM
IMPAX Labs (IPXL) To Report Fourth Quarter And Full Year 2015 Results On February 22, 2016 1/21/2016 7:33:55 AM
IMPAX Labs (IPXL) Receives Approval Of EMVERM (Mebendazole) Chewable Tablets, 100 Mg 1/15/2016 6:06:34 AM
IMPAX Labs (IPXL) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 9:52:49 AM
IMPAX Labs (IPXL) Receives European Commission (EC) Marketing Authorization For NUMIENT (Levodopa And Carbidopa) Modified-Release Capsules For The Symptomatic Treatment Of Adult Patients With Parkinson's Disease 11/25/2015 6:28:05 AM
IMPAX Labs (IPXL) Launches Generic Version Of Avodart (Dutasteride) Capsules, 0.5 mg 11/24/2015 7:28:53 AM
IMPAX Labs (IPXL) Reports Third Quarter 2015 Financial Results 11/9/2015 10:35:58 AM
IMPAX Labs (IPXL) To Present At The 24th Annual Credit Suisse Healthcare 11/5/2015 11:03:56 AM
IMPAX Labs (IPXL) Receives FDA Approval For Generic Version Of Intuniv (Guanfacine) Extended-Release Tablets, 1 mg, 2 mg, 3 mg And 4 mg 10/22/2015 8:42:02 AM
IMPAX Labs (IPXL) To Report Third Quarter 2015 Results On November 9, 2015 10/9/2015 7:00:01 AM